Delivery Order SPE2DB20D9103-SPE2DB22FE7A4

Award Date 11/17/21
Potential Completion Date 12/9/21
Potential Value $5.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Mirena 52 mg systems to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $59,200.00 and an ultimate completion date of October 18, 2024. DMS Pharmaceutical Group Inc. specializes in providing a wide range of pharmaceutical...
This federal contract award is for the delivery of Mirena 52 mg systems to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The total ceiling value of the contract is $11,840.00, and it is structured as a firm fixed-price delivery order with no set-aside designation. The contract has an ultimate completion date of August 28, 2024. DMS...
This federal contract award is for the delivery of Mirena 52 mg systems, a contraceptive implant, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $1,184 and a period of performance through July 3, 2024. DMS Pharmaceutical Group Inc. holds a larger $499,999,999...
The federal contract award is for the delivery of MIRENA 52 MG SYSTEMS to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This is a firm fixed-price delivery order contract valued at $7,104.00, with a period of performance through May 20, 2024. The contract is not associated with a set-aside program. DMS Pharmaceutical Group holds a larger...
This federal contract award is for the delivery of Mirena 52 mg systems to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $7,104.00 and an ultimate completion date of October 18, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with...
This federal contract award is for the delivery of Mirena 52 mg systems to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The prime contractor is DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $17,851.68 and a completion date of February 12, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of Mirena 52 mg systems to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense (DoD). The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $35,520.00 and a period of performance through September 20, 2024. The contract is not associated with a...
This federal contract award is for the delivery of Mirena 52 mg systems to the Defense Logistics Agency (DLA), a defense agency. The $2,603.85 firm fixed-price delivery order contract was awarded on March 13, 2025 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has an ultimate completion date of April 3, 2025 and is not associated with a set-aside designation. DMS Pharmaceutical Group Inc. holds a significant...
This federal contract award is for the delivery of Mirena 52 mg systems to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $5,074.50 and an ultimate completion date of September 27, 2021. The contract is not associated with any set-aside...
This federal contract award is for the delivery of Mirena 52 mg systems to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract has a ceiling value of $1,726.89 and is a firm fixed-price delivery order with no set-aside designation. The prime contractor is DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This award is part of a larger indefinite delivery contract (IDC) held by DMS...
  • SPE2DB20D9103
    Indefinite Delivery Contract
  • SPE2DB20D9103-SPE2DB22FE7A4
    Delivery Order

This federal contract award is for the delivery of Mirena 52 mg systems to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order with a firm fixed price of $5,074.50 and an ultimate completion date of December 9, 2021.

DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation, which enables DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains.

Generated 2/27/25, 12:24 PM